According to the latest report by IMARC Group, titled “Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global actinic keratosis treatment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/actinic-keratosis-treatment-market/requestsample
Actinic keratosis is a skin condition that is caused due to prolonged exposure to sun. Also known as solar keratosis, it results in rough, scaly patches that appear on the hands, scalp, arms, lips, and other body parts. It can further result in the development of a skin cancer called squamous cell carcinoma. Cryotherapy, curettage, laser therapy, and photodynamic therapy are commonly utilized for the treatment of actinic keratosis.
The global market is majorly driven by the rising prevalence of actinic keratosis and the growing need for preventive strategies for cancer. This can be accredited to the depletion of ozone layer and excessive exposure to sun. Moreover, several public and private organizations across the globe are focusing on conducting campaigns to spread awareness regarding the availability of treatments for actinic keratosis. Some of the other factors contributing to the market growth include the increasing demand for minimally invasive (MI) procedures, significant investments in research and development (R&D) activities and the introduction of topical treatment for actinic keratosis that are known to reduce the risks of scarring.
Actinic Keratosis Treatment Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global actinic keratosis treatment market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- 3M Company
- Almirall SA
- Bausch Health Companies Inc.
- Biofrontera Inc.
- BioLineRx Ltd.
- Cipher Pharmaceuticals Inc
- Galderma SA
- Hill Dermaceuticals Inc.
- LEO Pharma A/S
- Sun Pharmaceutical Industries Ltd.
Key Market Segmentation:
The report has segmented the global actinic keratosis treatment market on the basis of type, drug type, distribution channel applications and region.
Breakup by Type:
Breakup by Drug Type:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Stores
Breakup by Region:
- North America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/actinic-keratosis-treatment-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800